[Benzinga] HCA Holdings Inc (NYSE:HCA)(TREND ANALYSIS)
was also rated as Outperform, and received a $93 price target, which implies an upside potential of approximately 14.5 percent. The analysts base their rating on the belief that “investors are not fully valuing the company’s potential for accretive capital deployment and Parallon’s growth.”
According to the firm’s calculations, HCA could drive roughly 9 percent earnings upside via share repurchases by the end of 2017; the company has a three-year capital spending plan of $7.7 billion in place.
Stock Performance: Click here for a free comprehensive Trend Analysis Report
HCA Holdings Inc (NYSE:HCA) stock is currently trading 0.94% below its 52-week-high, 54.99% above its 52-week-low. The 1-year stock price history is in the range of $53.61 – $83.88. HCA Holdings Inc (HCA) has a price to earnings ratio of 17.45 versus Healthcare sector average of 26.5. HCA stock price has outperformed the S&P 500 by 11.8%. The Healthcare Services company is currently valued at $34.43 billion and its share price closed the last trading session at $83.09. The stock has a 50-day moving average of $78.87 and a 200-day moving average of $74.32.
HCA Holdings Inc (HCA) current short interest stands at 8.28 million shares. It has increased by 5% from the same period of last month. Around 3% of the company’s shares, which are float, are short sold. With a 10-days average volume of 2.74 million shares, the number of days required to cover the short positions stand at 3.1 days.
HCA reported last quarter earnings on May 05. The Healthcare Services company announced earnings per share of $1.35 against a consensus Street estimate of $1.34, beating the average estimate by $0.01. This corresponds to an increase of $0.48 compared to the same quarter of the previous fiscal year.
Is this a Buying Opportunity? Click here for a free Trend Analysis Report
There are currently twenty-two analysts that cover HCA Holdings Inc stock. Of those twenty-two, eighteen have a Buy rating, four have a Hold rating. On a consensus basis this yields to an Overweight rating. The consensus target price stands at $89.21.
A recent analyst activity consisted of Wedbush who initiated their coverage on the stock with Outperform rating on June 10. Wedbush fixed their price target at $93. This corresponds to a 11.93% upside from the last closing price. On the date of report, the stock closed at $83.09.
Credit Suisse reiterated their Outperform stance on May 6, and increased their price target on HCA stock from $81 to $84. This corresponds to a 1.1% upside from the last closing price. On the date of report, the stock closed at $74.5.
Another research firm was RBC Capital who reiterated their Outperform stance on May 6. RBC Capital increased their price target on HCA Holdings Inc from $88 to $93. This translates to a 11.93% upside from the last closing price. On the date of report, the stock closed at $74.5.
HCA Holdings, Inc. operates hospitals. The Company operates acute care hospitals, outpatient facilities, clinics and other patient care delivery settings. HCA operates hospitals in the United States and the United Kingdom.